Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$0.70 | $0.05 | -$0.22 |
| Q2 2025 | 6 | -$0.47 | $0.02 | -$0.25 |
| Q3 2025 | 4 | -$0.53 | -$0.10 | -$0.38 |
| Q4 2025 | 4 | -$0.57 | -$0.22 | -$0.34 |
| Q1 2026 | 4 | -$0.42 | -$0.17 | -$0.29 |
| Q2 2026 | 1 | -$0.31 | -$0.26 | -$0.28 |
| Q3 2026 | 1 | -$0.28 | -$0.24 | -$0.26 |
| Q4 2026 | 1 | -$0.28 | -$0.24 | -$0.26 |
| Q1 2027 | 1 | -$0.28 | -$0.24 | -$0.26 |
| Q2 2027 | 1 | -$0.31 | -$0.26 | -$0.28 |
| Q3 2027 | 1 | -$0.25 | -$0.22 | -$0.23 |
| Q4 2027 | 1 | -$0.30 | -$0.26 | -$0.28 |
RxSight, Inc. last posted its earnings results on Wednesday, November 5th, 2025. The company reported $-0.04 earnings per share for the quarter, topping analysts' consensus estimates of $-0.19 by $0.15. The company had revenue of 30.34 M for the quarter and had revenue of 139.93 M for the year. RxSight, Inc. has generated $-1 earnings per share over the last year ($-0.71 diluted earnings per share) and currently has a price-to-earnings ratio of -14.98. RxSight, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 24th, 2026 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2025 | Q3 2025 | -$0.19 | -$0.24 | -0.05 | $25.28 M | $30.34 M |
| 08/07/2025 | Q2 2025 | -$0.10 | -$0.29 | -0.19 | $34.79 M | $33.64 M |
| 05/07/2025 | Q1 2025 | -$0.04 | -$0.20 | -0.16 | N/A | $37.90 M |
| 02/25/2025 | Q4 2024 | $0.10 | -$0.15 | -0.25 | N/A | $40.21 M |
| 11/07/2024 | Q3 2024 | -$0.25 | -$0.16 | 0.09 | $35.06 M | $45.41 M |
| 08/05/2024 | Q2 2024 | -$0.22 | -$0.16 | 0.06 | $32.33 M | $34.89 M |
| 05/06/2024 | Q1 2024 | -$0.17 | -$0.25 | -0.08 | N/A | $29.51 M |
| 12/29/2023 | Q4 2023 | N/A | -$0.26 | N/A | N/A | $28.58 M |
| 11/09/2023 | Q3 2023 | -$0.42 | -$0.35 | 0.07 | $20.55 M | $30.67 M |
| 08/07/2023 | Q2 2023 | -$0.47 | -$0.40 | 0.07 | $19.23 M | $20.81 M |
| 05/09/2023 | Q1 2023 | -$0.52 | -$0.47 | 0.05 | $16.28 M | $17.49 M |
| 03/06/2023 | Q4 2022 | -$0.72 | -$0.56 | 0.16 | $15.85 M | $16.09 M |
| 11/07/2022 | Q3 2022 | -$0.70 | -$0.61 | 0.09 | $10.98 M | $12.62 M |
| 08/08/2022 | Q2 2022 | -$0.68 | -$0.61 | 0.07 | $10.55 M | $11.36 M |
| 05/05/2022 | Q1 2022 | -$0.56 | -$0.64 | -0.08 | $7.32 M | $8.94 M |
| 03/08/2022 | Q4 2021 | -$0.58 | -$0.58 | 0 | $7.64 M | $8.43 M |
| 11/10/2021 | Q3 2021 | -$0.61 | -$0.68 | -0.07 | $5.22 M | $5.79 M |
| 09/09/2021 | Q2 2021 | -$0.68 | -$0.51 | 0.17 | $4.92 M | $4.90 M |
| 03/30/2021 | Q1 2021 | N/A | -$0.36 | N/A | N/A | $3.48 M |
| 12/30/2020 | Q4 2020 | N/A | $1.38 | N/A | N/A | $4.91 M |
RxSight, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 24th, 2026 based offlast year's report dates.
In the previous quarter, RxSight, Inc. (:RXST) reported $-0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.19 by $0.15.
The conference call for RxSight, Inc.'s latest earnings report can be listened to online.
The conference call transcript for RxSight, Inc.'s latest earnings report can be read online.
RxSight, Inc. (:RXST) has a recorded annual revenue of $139.93 M.
RxSight, Inc. (:RXST) has a recorded net income of $-27,455,000.RxSight, Inc. has generated $-0.71 earnings per share over the last four quarters.
RxSight, Inc. (:RXST) has a price-to-earnings ratio of -14.98 and price/earnings-to-growth ratio is 0.77.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED